WhaleWatch logoWhaleWatch
Sign inStart for ₹1
Smart Money Alert
Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited

New PositionSAST
BLISSGVSPharmaceuticalsMarket Cap₹7K Cr
Deal value
₹3760.88 Cr
Shares
5.10 Cr
Trade date
28 Sept 2026
Since alert−3.6%₹664.80 → ₹640.55
Nifty 50+14.4%
MA
Mates Visa Consultancy Private Limited
Promoter
The move

Mates Visa Consultancy Private Limited acquired 5,09,84,595 shares of Bliss GVS Pharma Limited, representing a 47.95% stake, pursuant to a Share Purchase Agreement.

About Bliss GVS Pharma Limited
+ FollowVisit stock

A pharmaceutical manufacturer engaged in producing and marketing a diverse range of formulations including suppositories, pessaries, capsules, tablets, and syrups. The company operates across manufacturing, marketing, trading, and export functions, serving both domestic and international markets. Established in 1984, it has developed specialized expertise in multiple dosage forms and maintains an integrated operation across the pharmaceutical value chain to address varied healthcare requirements.

Get the next move the moment it happens.
Follow the investors and Bliss GVS Pharma Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
Explore
Bliss GVS Pharma Limited shareholdersAll investorsAll stocks
🤖 We track their every move, post, interview and article. Obsessively.
⚡ Every move reaches your feed in minutes, while it still carries an edge
📊 Stake changes, bulk deals and insider trades, all tracked in one place
📰 A two-minute morning brief, so you start the day already ahead
Bliss GVS Pharma Limited
More moves in Bliss GVS Pharma Limited
1newest move
Members only
Xxxxxx Xxxxxxxxxxxx xxxxxxx xxx xxxxx
Unlock this move
LICDecreased
LIC cut its stake in Bliss GVS Pharma from 3.24% to 1.53%, selling 18,16,071 shares.
22 Oct 2026
Read more
LICDecreased
LIC sold 21,32,071 shares of Bliss GVS Pharma in the open market, decreasing its stake from 5.11% to 2.96%.
10 Aug 2026
Read more
Quadrature Capital Vector SpExited
Quadrature Capital Vector Sp, which last held a 1.23 percent stake in Bliss GVS Pharma Limited, is no longer listed among the company's disclosed shareholders, indicating either a complete exit or a reduction in their holding to below the 1 percent disclosure threshold.
22 Jul 2026
Read more
360 ONE AIFNew position
360 ONE AIF entered Bliss GVS Pharma with 12,30,285 shares, a 1.16% stake.
22 Jul 2026
Read more
See all moves